Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="898876000"
EBITDA="-177218000"
PERatio="None"
PEGRatio="None"
BookValue="3.865"
DividendPerShare="0"
DividendYield="0"
EPS="-2.91"
RevenuePerShareTTM="0.626"
ProfitMargin="0"
OperatingMarginTTM="-5.33"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-0.793"
RevenueTTM="33609000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-2.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.66"
AnalystTargetPrice="37.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.684"
num_52WeekHigh="34.99"
num_52WeekLow="4.48"
num_50DayMovingAverage="17.44"
num_200DayMovingAverage="22.85"
SharesOutstanding="56855000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="15.86"
high="16.11"
low="15.63"
price="15.81"
volume="660351.00"
latest_trading_day="2023-07-07"
previous_close="15.86"
change="-0.05"
change_percent="-0.3153%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="92"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="8"
Volume_recent_avg="705234"
Change_recent_avg="-0.08"
Delta_recent_avg="1.07"
Variance_recent_avg="0.54"
Change_ratio_recent_avg="-0.43"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="8"
Aroon_momentum_negative="92"
image_negative_thumbnail_id_1="1133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="670"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_positive_thumbnail_id_2="957"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
